Can­cer re­searcher in­vested to Or­der of Canada

The Hamilton Spectator - - LOCAL -

Hamil­ton can­cer re­searcher Dr. Mark Levine is be­ing in­vested to the Or­der of Canada at Rideau Hall on Friday.

The med­i­cal on­col­o­gist at Hamil­ton Health Sci­ences and McMaster Univer­sity has shaped can­cer pro­gram­ming and in­flu­enced treat­ment par­tic­u­larly in breast can­cer start­ing with his first trial in 1982.

Levine is re­ceiv­ing the Or­der of Canada for “his con­tri­bu­tions as an on­col­o­gist, re­searcher, and clin­i­cian who has de­vel­oped a num­ber of new treat­ment reg­i­mens that have be­come the Cana­dian stan­dard in clin­i­cal prac­tice.”

He was CEO of the for­mer Hamil­ton Re­gional Can­cer Cen­tre — now Ju­ravin­ski Can­cer Cen­tre — for seven years start­ing in 1992. Levine was also the first chair of the depart­ment of on­col­ogy at McMaster Univer­sity and has held the post since 2007. In 2011, he es­tab­lished the Es­carp­ment Can­cer Re­search In­sti­tute.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.